Disclosures
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.
Faculty Disclosures
The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:
- Sergio D. Bergese, MD, has received grant/research support from Canyon, Covidien, Eisai, Pacira, and Pfizer. He has served as a consultant for Baxter and Stryker.
- John W. Devlin, PharmD, BCPS, FCCM, FCCP, has received grant/research support from and served as a consultant for Hospira.
- E. Wesley Ely, MD, has received grant/research support from, served as a consultant for, and received honoraria from Aspect, GlaxoSmithKline, Hospira, Masimo, and Pfizer.
- Pratik Pandharipande, MD, has received grant/research support from Hospira. He has received honoraria from GlaxoSmithKline, Hospira, and Orion Pharma.
- Brenda T. Pun, RN, MSN, ACNP, has received honoraria from Hospira.
- Richard R. Riker, MD, has served as a consultant for Masimo.
Unapproved Use Disclosure
The France Foundation requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Commercial Support Acknowledgment
This activity is supported by an educational grant from Hospira.
Disclaimer
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and Hospira assume no liability for the information herein.
